Tarantula venom-based MD therapy to be advanced by UB scientists' biotech company
Tuesday, December 29, 2009 - 13:21
in Health & Medicine
University at Buffalo biophysicists have found a protein in tarantula venom that shows promise as a potential therapy for muscular dystrophy (MD). They have formed a start-up biotech company in Buffalo -- Rose Pharmaceuticals -- to advance the drug to clinical trials.